⌘K
Loading ticker…
Phathom Pharmaceuticals, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Phathom Pharmaceuticals, Inc. Common Stock (PHAT) has a 3-month relative strength percentile of 38 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.5%, relative volume 2.48×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
38 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
PHAT is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -5.2% / -15.7%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
PHAT is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $22M notional. Top 3 carry $40M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $22M |
| IWMiShares Russell 2000 ETF | 0.02% | $12M |
| VXFVanguard Extended Market ETF | 0.01% | $6M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.44% | $4M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $1M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $853K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PHAT Jan avg: -16.03% median: -21.92% win: 25% σ: 15.47% n: 4 2022-04-12 → 2026-05-29 | PHAT Feb avg: 3.87% median: -7.98% win: 25% σ: 38.43% n: 4 2022-04-12 → 2026-05-29 | PHAT Mar avg: -3.82% median: -6.15% win: 25% σ: 13.36% n: 4 2022-04-12 → 2026-05-29 | PHAT Apr avg: -1.97% median: -13.96% win: 40% σ: 31.16% n: 5 2022-04-12 → 2026-05-29 | PHAT May avg: -9.13% median: -0.93% win: 40% σ: 21.77% n: 5 2022-04-12 → 2026-05-29 | PHAT Jun avg: 43.62% median: 19.74% win: 100% σ: 54.93% n: 4 2022-04-12 → 2026-05-29 (current) | PHAT Jul avg: 4.79% median: 7.67% win: 75% σ: 11.07% n: 4 2022-04-12 → 2026-05-29 | PHAT Aug avg: 17.43% median: 17.19% win: 50% σ: 27.47% n: 4 2022-04-12 → 2026-05-29 | PHAT Sep avg: 1.97% median: 3.04% win: 50% σ: 24.15% n: 4 2022-04-12 → 2026-05-29 | PHAT Oct avg: -1.17% median: -4.74% win: 25% σ: 11.18% n: 4 2022-04-12 → 2026-05-29 | PHAT Nov avg: -15.92% median: -15.34% win: 25% σ: 27.09% n: 4 2022-04-12 → 2026-05-29 | PHAT Dec avg: 10.20% median: 9.32% win: 75% σ: 16.18% n: 4 2022-04-12 → 2026-05-29 |